- Research article
- Open Access
- Open Peer Review
Positive association of tomato consumption with serum urate: support for tomato consumption as an anecdotal trigger of gout flares
BMC Musculoskeletal Disorders volume 16, Article number: 196 (2015)
Gout is a consequence of an innate immune reaction to monosodium urate crystals deposited in joints. Acute gout attacks can be triggered by dietary factors that are themselves associated with serum urate levels. Tomato consumption is an anecdotal trigger of gout flares. This study aimed to measure the frequency of tomato consumption as a self-reported trigger of gout attacks in a large New Zealand sample set, and to test the hypothesis that tomato consumption is associated with serum urate levels.
Two thousand fifty one New Zealanders (of Māori, Pacific Island, European or other ancestry) with clinically-ascertained gout were asked about gout trigger foods. European individuals from the Atherosclerosis Risk In Communities (ARIC; n = 7517) Study, Cardiovascular Health Study (CHS; n = 2151) and Framingham Heart Study (FHS; n = 3052) were used to test, in multivariate-adjusted analyses, for association between serum urate and tomato intake.
Seventy one percent of people with gout reported having ≥1 gout trigger food. Of these 20 % specifically mentioned tomatoes, the 4th most commonly reported trigger food. There was association between tomato intake and serum urate levels in the ARIC, CHS and FHS combined cohort (β = 0.66 μmolL−1 increase in serum urate per additional serve per week; P = 0.006) - evident in both sexes (men: β = 0.84 μmolL−1, P = 0.035; women: β = 0.59 μmolL −1, P = 0.041).
While our descriptive and observational data are unable to support the claim that tomato consumption is a trigger of gout attacks, the positive association between tomato consumption and serum urate levels suggests that the self-reporting of tomatoes as a dietary trigger by people with gout has a biological basis.
High serum urate levels are the major risk factor for gout . Urate levels are maintained within the body through a balance between urate production (hepatic) and excretion (renal and gut), controlled by genetic and dietary factors . When urate levels reach supersaturation monosodium urate crystals may deposit within the joints and elicit an immune reaction . Variants in genes encoding renal and gut uric acid transporters are associated with urate levels and gout [4–8], while serum urate-controlling variants of weaker effect map to loci thought to be involved in glycolysis and other pathways enriched for inhibins and activins .
Foods and beverages positively associated with serum urate and gout are alcohol (particularly beer), purine-rich foods, red meat, seafood, and sugar-sweetened beverages [9–15]. Conversely, intake of coffee, dairy products and vitamin C have been associated with lowered serum urate levels and reduced risk of gout [11, 16–20]. Urate is generated from breakdown of purines and as a consequence of hepatic metabolism of alcohol and sugar, with evidence that both ethanol and sugar also interfere with renal excretion of uric acid [9, 21]. Gout is often associated with dietary triggers, commonly perceived by patients to be the most important cause of gout . Demonstrated food triggers, identified using case-crossover study design, include alcohol and purine-rich foods [23, 24]. These foods also increase serum urate levels [12, 15, 25], consistent with the hypothesis that they trigger acute gout attacks. People with gout also self-report food avoidances that have not been substantiated by the medical literature – these avoidances include tomatoes and tomato products .
This study aimed to determine the frequency of tomato consumption as a self-reported trigger of gout flares in a large gout sample set from New Zealand (including Māori and Pacific Island participants). These groups have a prevalence of gout double that of European Caucasian , with earlier onset, more severe gout presentation and a higher prevalence of co-morbidities . We also tested the hypothesis that tomato consumption is associated with serum urate levels.
New Zealand men and women >17 years of age with gout (n = 1791) (recruited as part of a study focused on the risk factors for gout)  were asked the question “Do certain foods/drinks trigger your gout?” Patients were prompted to specify whether alcohol or seafood triggered their gout, then given the opportunity to list other gout trigger foods/drinks in an open-question format. Responses to the same question by a separate Māori sample set from the rohe (area) of the Ngati Porou iwi (tribe), patients of the primary health care provider Ngati Porou Hauora (health) Charitable Trust, in the Tairawhiti region on the East Coast of the North Island of New Zealand were also analysed (260 people with gout). All participants had a confirmed diagnosis of gout, as defined by the 1977 American Rheumatology Association preliminary classification criteria for acute gout . They were recruited from community-based settings, and primary and secondary health care. Ethical approval was given by the New Zealand Multi-Region and Northern Y Ethics Committees and all participants provided written informed consent for the collection of samples and subsequent analysis. Anthropometric, clinical and gout attack trigger information for each analysis cohort are contained in Additional file 1: Table S1.
Trigger foods were summarised into ten categories (alcohol, dairy products, fruit, poultry, red meat, seafood/fish, sugar-sweetened beverages, tomatoes, vegetables, and other) and the percentage of people who mentioned each category calculated – split also into five ancestral groups, New Zealand Māori, Ngati Porou Māori, New Zealand Pacific Island, European and Other. Multivariate logistic regression adjusted for sex, age at first attack, body mass index, and number of flares per year was conducted to determine whether ancestry influenced the reporting of acute gout attack triggers.
Data from the Atherosclerosis Risk in Communities (ARIC) (http://www2.cscc.unc.edu/aric/), Cardiovascular Health Study (CHS) (https://chs-nhlbi.org/) and Framingham Heart Study (FHS) Generation 3 (http://www.framinghamheartstudy.org/) cohorts were used to test the hypothesis that tomato consumption is associated with serum urate levels. All three studies recruited individuals from North America. Participants in these studies completed a food frequency questionnaire that asked “How often, on average, did you eat tomatoes or tomato juice in the past year?” (Tomato sauce information was also collected, but excluded for this analysis). The questionnaire also asked about consumption of seafood/fish (canned tuna fish, dark meat fish, shrimp, lobster, scallops, and other fish), red meat (beef, pork, lamb, bacon, processed meat, hamburgers, and hotdogs), alcohol (beer, wine, and liquor), sugar-sweetened drinks (regular soft drink and non-carbonated fruit drink), coffee (not decaffeinated) and dairy products (milk, cream, butter, margarine, ice cream, cheese and yoghurt). Vitamin C intake (mg/day) was also measured in each of these studies. Study participants were asked to answer these questions by choosing from food frequency categories (9 categories in ARIC and FHS, with 1 indicating almost never, whilst 9 indicated ≥6 serves per day; 6 categories in CHS, with 1 indicating never whilst 6 indicated almost every day). These categorical answers were converted to average serves per week for analysis (Additional file 2: Table S2). Serum urate levels (μmolL−1) were also measured at the time of data collection (ARIC Visit 1: 1987–1989; uricase oxidation method ; CHS Baseline collection: 1989–1990; measured with a Kodak Ektachem 700 analyser with reagents ; FHS Generation 3 Exam 1: 2002–2005, auto-analysed with a phosphotungstic acid reagent ).
European sample sets for analysis were developed for each of the ARIC, FHS and CHS data sets following consistent exclusion criteria between groups (Additional file 3: Figure S1). People without serum urate measurements or genome-wide genotyping were excluded along with non-European individuals and individuals with kidney disease, established gout, taking urate-lowering drugs, or on diuretic medication. Quality controls for the food frequency data were also used, with individuals who answered less than 10 % of the food frequency survey excluded, along with individuals whose average daily calorie intake was less than 600 kcal/day and greater than 4200 kcal/day. This left 12,720 individuals for analysis (ARIC: 7517, 52 % female, age range 44–65; CHS: 2151, 59 % female, age range 64–97; and FHS: 3052, 54 % female, age range 19–72). Anthropometric, clinical and dietary information for each analysis cohort are contained in Additional file 4: Table S3.
Multivariate linear regression adjusted for common risk factors (sex, age, body mass index and menopausal status), whole-genome principal component analysis vectors 1 and 2 (PCA1 and PCA2) and average daily calorie intake (kcal/day), along with other known dietary triggers, was conducted and the results for the separate ARIC, CHS and FHS sample sets combined by inverse-variance weighted meta-analysis. The ARIC, CHS and FHS cohorts were further divided into male only (ARIC: 3614, CHS: 877, FHS: 1394) and female only (ARIC: 3903, CHS: 1274, FHS: 1658) subsets, on which multivariate linear regression adjusted for age, body mass index, PCA1, PCA2 and calorie intake (and menopausal status in the women only subsets) was performed and the sample sets again combined by meta-analysis. Multivariate linear regression between serum urate levels and each of the known dietary trigger foods (using the same adjustments as stated previously) was also performed for all individuals and the male and female only subsets (Additional file 5: Table S4). All statistical analysis was performed using R v3.0.2 (http://www.R-project.org/). Meta-analysis using an inverse-variance fixed effect model was performed using the R package “meta 3.1-1” (http://cran.r-project.org/web/packages/meta/).
Of the 2051 New Zealand men and women with gout who were surveyed, 1447 (70.6 %) self-reported ≥1 food or drink trigger of acute gout attacks; 905 (62.5 %) specified seafood or fish, 681 (47.1 %) alcohol, 509 (35.2 %) red meat and 292 (20.2 %) tomatoes (Fig. 1); with 69.4 % specifying >1 trigger. Vegetables, fruit and sugar-sweetened drinks ranked fifth, sixth, and seventh most common reported trigger foods, respectively. Triggers were more commonly reported in New Zealand Māori, Ngati Porou Māori and New Zealand Pacific Island people than European (76.2, 79.1, 88.3 and 57.8 %, respectively). Compared to European, after adjusting for factors influencing the severity of gout, New Zealand Pacific Island people were 3.87-fold (95 % confidence interval (2.72 to 5.61), P = 1.9x10−13), New Zealand Māori 1.91-fold ((1.38 to 2.68), P = 1.3x10−4) and Ngati Porou Māori 3.00-fold ((1.98 to 4.66), P = 4.7x10−7) more likely to self-report a trigger of gout attacks. Similarly Pacific Island people, New Zealand Māori and Ngati Porou Māori were more likely to self-report tomatoes as a trigger of gout flares (1.48-fold ((1.02 to 2.18), P = 0.04); 1.98-fold ((1.32 to 2.97), P = 8.8x10−4); 2.58-fold ((1.69 to 3.93), P = 1.0x10−5), respectively) than those of European descent.
The three most commonly mentioned dietary triggers of gout have been positively correlated with serum urate levels [12, 15, 25]. Therefore we hypothesised that tomatoes, the fourth most common self-reported trigger of gout flares in New Zealand, also increase serum urate levels. We tested for association between tomato consumption and serum urate in the ARIC, CHS and FHS European Caucasian sample sets. A positive association was observed in the ARIC sample set (β = 0.91 μmolL−1 increase in serum urate per additional serve per week of tomatoes, P = 0.006) with a positive direction in CHS and FHS (β = 0.22 μmolL−1, P = 0.79 and β = 0.43 μmolL−1, P = 0.27 respectively). There was positive association in the combined samples (β = 0.66 μmolL−1, P = 0.006) (Table 1). The association was also seen in both the men only and women only sub-sets, with a larger effect size in the men only group (men: β = 0.84 μmolL−1, P = 0.035; women: β = 0.59 μmolL−1, P = 0.041) (Table 1).
The association between tomato consumption and serum urate levels was maintained after adjustment for other accepted food triggers, both in a univariate model (red meat: β = 0.69 μmolL−1 per additional serving of tomatoes per week, P = 0.008; seafood/fish: β = 0.58 μmolL−1, P = 0.029; sugar-sweetened soft drinks/juices: β = 0.72 μmolL−1, P = 0.006; dairy products: β = 0.60 μmolL−1, P = 0.019; coffee: β = 0.67 μmolL−1, P = 0.011; vitamin C: β = 0.78 μmolL−1, P = 0.004; alcohol: β = 0.53 μmolL−1, P = 0.024), and a multivariate model (β = 0.66 μmolL−1, P = 0.008) (Table 2). Data from the separate sample sets are presented in Additional file 5: Table S4.
The nutritional exposure data for the specific food items used in this study have previously been validated for the separate ARIC, CHS and FHS cohorts [34–37]. To empirically investigate the validity of the nutritional exposure data we tested four specific foods accepted as urate-raising and conferring of risk of gout (red meat, seafood/fish, sugar-sweetened beverages, alcohol) [9–13] and one urate-lowering and gout protective (dairy products) [11, 12]. Each of these foods was associated with urate, in the expected direction, in either the combined (seafood/fish, dairy products, alcohol) or sex-specific (red-meat, sugar-sweetened beverages) analysis (Additional file 6: Table S5).
Tomatoes are the fourth most common self-reported trigger of gout attacks in a New Zealand sample set. New Zealand Pacific Island, New Zealand Māori and Ngati Porou Māori people were more likely to self-report a trigger of gout flares than European Caucasian (3.87, 1.91 and 3.00-fold, respectively). This was independent of indicators of severity, including number of acute attacks per year. It is possible that self-recognition of attack triggers is a reflection of a greater community familiarity with gout due to a higher prevalence and longer disease history in Pacific Island and Māori populations, with evidence for gout in these populations pre-Westernisation [38, 39]. Tomato has also previously been reported as a food avoided by Australian gout patients, with the authors noting that the current evidence does not support this avoidance .
Here we provide evidence that tomato consumption is positively associated with serum urate in European Caucasians suggesting that the avoidance of tomatoes by gout patients (due to identification as triggers of acute gout attacks) is not an unfounded practice. Whilst our data cannot support the claim that tomato consumption is a trigger of gout attacks we provide support for the hypothesis that tomato consumption may trigger gout attacks through increasing serum urate. In order to assess the clinical relevance of these data it is useful to compare the increase in serum urate attributed to a one serve per week increase in tomato consumption (0.7 μmolL−1) with other recognised gout attack trigger foods that also increase serum urate (men and women combined). Alcohol increased serum urate by 2.3 μmolL−1 per serving per week in the United States third National Health and Nutrition Examination Survey (NHANES) . In the ARIC sample set sugar-sweetened drinks increased urate 0.4 μmolL−1 per serve per week , and in the third NHANES sample set total meat and seafood increased urate 0.5 μmolL−1 and 2.4 μmolL−1 per extra serve per week, respectively . Thus tomatoes alter serum urate levels to an extent comparable to other established dietary risk factors for gout.
To assess the causal influence of tomatoes on serum urate levels intervention studies need to be conducted. Small studies investigating the influence of tomatoes or tomato products on other biomarkers have been conducted, with several measuring urate levels before and after intervention took place (Table 3) [40–46]. Lee et al.  found an average increase of 46 μmolL−1 (P < 0.05) in plasma urate levels in a small cohort of young Chinese men (n = 10, 26 ± 1 years) 48 h after consumption of 150 g tomato sauce . Conversely a recent study by Vinha et al.  found an average drop of 10 μmolL−1 in plasma urate levels (P < 0.05) in a cohort of young women (n = 35, 19.6 ± 1.3 years) who ingested a ~90 g tomato before their midday meal for 30 consecutive days. Four additional intervention studies were unable to find any significant difference in serum or plasma urate levels after intervention [40, 41, 44, 45]. Similarly Jacob et al.  found no significant difference in the plasma urate levels of 12 individuals (23 ± 2 years) after consumption of 500 mL tomato juice per day for 2 weeks, however an increase in renal urate clearance (urate:creatinine ratio) was observed in these individuals (P < 0.05). Only the study conducted by Vinha et al.  used whole tomato fruit as the intervention product, more commonly tomato juice or sauce was used in these studies. This creates the possibility that other additives or the concentrated nature or the processing (eg production and loss of urate-influencing chemicals) of these products influence urate levels, such as sugars (2-3 % content) or added vitamin C (0-4 % content). Generally, the demographics of the groups studied (Table 3) are different (younger) to the group in which we associated tomato consumption with serum urate levels (Additional file 4: Table S3). In the case of Vinha et al.  their conclusion that the changes in biochemical and anthropometric parameters may be due to a decrease in postprandial hunger suggests the decrease in plasma urate levels observed could be due to a decrease in consumption of other serum urate-raising foods between meals rather than solely the function of tomato consumption itself. The influence of other serum urate-raising foods was accounted for in our analysis.
The association we have seen between tomatoes and serum urate supports the hypothesis of a possible effect of tomatoes on either hepatic urate production or renal uric acid handling. Any effect of tomatoes on renal uric acid excretion could be mediated by phenolic acid. The inhibitory effects of nine phenolic acid compounds on three renally expressed organic anion transporters (OAT1, OAT3, and OAT4) have been tested , all of which transport uric acid . All compounds modified the capability of OAT1 and OAT3 to transport endogenous substrates in vitro, whilst two compounds (syringic acid and sinapinic acid) weakly affected OAT4 . Some of the OAT1/OAT3 interacting compounds (p-coumaric acid, ferullic acid, p-hydroxybenzoic acid and vanillic acid) are present in tomatoes . Of these three transporters, only OAT4 (encoded by SLC22A11) has been genetically associated with serum urate and gout [4, 5, 8, 29].
Alternatively tomatoes may be influencing urate levels through increased production. Urate is the end product of purine break-down in humans, and consumption of foods with a high purine-content (red meats, seafood, beer) results in raised serum urate levels and risk of gout [10–12, 25]. Tomatoes, however, have a very low purine-content . Instead tomatoes contain high levels of glutamate, an amino acid which is often found in foods with a high purine-content and is able to stimulate or amplify the synthesis of urate by acting as a nitrogen donor in the purine synthesis pathway [50, 51].
How an increase in serum urate levels could cause an attack of gout is currently not resolved. Intra-articular injection of urate does not induce inflammatory arthritis as compared to monosodium urate (MSU) crystal injection  and a well-established trigger of gout attacks is a decrease in urate, for example from initiation of urate-lowering therapy, believed to be caused by crystal shedding in the joint. However, all established dietary triggers of gout flares are characterised by a positive association between consumption and serum urate [12, 15, 25], suggesting that dietary-induced increases in serum urate are important in gout attacks. Given, however, that MSU nucleation and crystal growth is slow compared to dissolution  it is possible that the observed dietary-associations with serum urate may require other factors to induce acute gout attacks, for example an increase in free-fatty acids that could be within or induced by the trigger food .
To our knowledge this is the first time tomatoes have been associated with serum urate, suggesting that the avoidance of tomatoes by people with gout may have a biological basis. Further research into the relationship between gout (and onset of gout attacks) and tomatoes needs to be conducted, to further investigate this relationship, potentially with a case-crossover study design, as previously used to demonstrate a purine-rich diet and alcohol as triggers of acute gout attacks [22, 24]. Analysis of any effect on urinary uric acid excretion and glutamate metabolism is also required to identify the mechanisms behind this association.
The positive association between tomato consumption and serum urate levels supports the hypothesis that the self-reporting of tomatoes as a dietary trigger by people with gout has a biological basis.
Atherosclerosis Risk in Communities
Cardiovascular Health Study
Framingham Heart Study
National Health and Nutrition Examination Survey
Organic anion transporter
Principal component analysis
Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med. 1987;82:421–6.
Robinson PC, Horsburgh S. Gout: Joints and beyond, epidemiology, clinical features, treatment and co-morbidities. Maturitas. 2014;78:245–51.
Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440:237–41.
Phipps-Green A, Merriman M, Topless R, Altaf S, Montgomery GW, Franklin C, Jones GT, van Rij AM, White D, Stamp LK, Dalbeth N, Merriman TR: Twenty-eight loci that influence serum urate levels: analysis of association with gout. Ann Rheum Dis 2014, Sep 3. pii: annrheumdis-2014-205877. doi: 10.1136/annrheumdis-2014-205877. (Epub ahead of print)
Köttgen A, Albrecht E, Teumer A, Vitart V, Krumsiek J, Hundertmark C, et al. Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet. 2013;45:145–54.
Merriman TR, Choi HK, Dalbeth N. The genetic basis of gout. Rheum Dis Clin North Am. 2014;40:279–90.
Merriman TR. Population heterogeneity in the genetic control of serum urate. Semin Nephrol. 2011;31:420–5.
Urano W, Taniguchi A, Inoue E, Sekita C, Ichikawa N, Koseki Y, et al. Effect of genetic polymorphisms on development of gout. J Rheumatol. 2013;40:1374–8.
Batt C, Phipps-Green A, Black MA, Cadzow M, Merriman ME, Topless R, et al. Sugar-sweetened beverage consumption: a risk factor for prevalent gout that interacts with SLC2A9 genotype-specific effects on serum urate and risk of gout. Ann Rheum Dis. 2014;73:2101–6.
Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Alcohol intake and risk of incident gout in men: a prospective study. Lancet. 2004;363:1277–81.
Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med. 2004;350:1093–103.
Choi HK, Liu S, Curhan G. Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: The Third National Health and Nutrition Examination Survey. Arthritis Rheum. 2005;52:283–9.
Choi HK, Willett W, Curhan G. Fructose-rich beverages and risk of gout in women. JAMA. 2010;304:2270–8.
Hak AE, Choi H. Menopause, postmenopausal hormone use and serum uric acid levels in US women - The Third National Health and Nutrition Examination Survey. Arthritis Res Ther. 2008;10:R116.
Rasheed H, Phipps-Green A, Topless R, Hollis-Moffatt JE, Hindmarsh JH, Franklin C, et al. Association of the lipoprotein receptor-related protein 2 gene with gout and non-additive interaction with alcohol consumption. Arthritis Res Ther. 2013;15:R177.
Choi HK, Curhan G. Coffee consumption and risk of incident gout in women: the Nurses' Health Study. Am J Clin Nutr. 2010;92:922–7.
Choi HK, Curhan G. Coffee, tea, and caffeine consumption and serum uric acid level: the third national health and nutrition examination survey. Arthritis Rheum. 2007;57:816–21.
Choi HK, Gao X, Curhan G. Vitamin c intake and the risk of gout in men: A prospective study. Arch Intern Med. 2009;169:502–7.
Choi HK, Willett W, Curhan G. Coffee consumption and risk of incident gout in men: a prospective study. Arthritis Rheum. 2007;56:2049–55.
Huang HY, Appel LJ, Choi MJ, Gelber AC, Charleston J, Norkus EP, et al. The effects of vitamin C supplementation on serum concentrations of uric acid: results of a randomized controlled trial. Arthritis Rheum. 2005;52:1843–7.
Lieber CS, Jones DP, Losowsky MS, Davidson CS. Interrelation of uric acid and ethanol metabolism in man. J Clin Invest. 1962;41:1863–70.
Dalbeth N, Petrie KJ, House M, Chong J, Leung W, Chegudi R, et al. Illness perceptions in patients with gout and the relationship with progression of musculoskeletal disability. Arthritis Care Res. 2011;63:1605–12.
Zhang Y, Chen C, Choi H, Chaisson C, Hunter D, Niu J, et al. Purine-rich foods intake and recurrent gout attacks. Ann Rheum Dis. 2012;71:1448–53.
Zhang Y, Woods R, Chaisson CE, Neogi T, Niu J, McAlindon TE, et al. Alcohol consumption as a trigger of recurrent gout attacks. Am J Med. 2006;119:e13–18.
Choi HK, Curhan G. Beer, liquor, and wine consumption and serum uric acid level: The Third National Health and Nutrition Examination Survey. Arthritis Care Res. 2004;51:1023–9.
Shulten P, Thomas J, Miller M, Smith M, Ahern M. The role of diet in the management of gout: a comparison of knowledge and attitudes to current evidence. J Hum Nutr Diet. 2009;22:3–11.
Winnard D, Wright C, Taylor WJ, Jackson G, Te Karu L, Arroll B, et al. National prevalence of gout derived from administrative health data in Aotearoa New Zealand. Rheumatology (Oxford). 2012;51:901–9.
Hollis-Moffatt JE, Phipps-Green AJ, Chapman B, Jones GT, van Rij A, Gow P, et al. The renal urate transporter SLC17A1 locus: confirmation of association with gout. Arthritis Res Ther. 2012;14:R92. doi:10.1186/ar3816.
Flynn T, Phipps-Green A, Hollis-Moffatt JE, Merriman ME, Topless R, Montgomery GW, et al. Association analysis of the SLC22A11 (organic anion transporter 4) and SLC22A12 (urate transporter 1) urate transporter locus with gout in New Zealand case–control sample sets reveals multiple ancestral-specific effects. Arthritis Res Ther. 2013;15:R220.
Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu TF. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum. 1977;20:895–900.
Investigators ARIC. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol. 1989;129:687–702.
Cushman M, Cornell ES, Howard PR, Bovill EG, Tracy RP. Laboratory methods and quality assurance in the Cardiovascular Health Study. Clin Chem. 1995;41:264–70.
Crowley LV. Determination of uric acid an automated analysis based on a carbonate method. Clin Chem. 1964;10:838–44.
Kumanyika S, Tell GS, Fried L, Martel JK, Chinchilli VM. Picture-sort method for administering a food frequency questionnaire to older adults. J Am Diet Assoc. 1996;96:137–44.
Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol. 1992;135:1114–26.
Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol. 1985;122:51–65.
Stevens J, Metcalf PA, Dennis BH, Tell GS, Shimakawa T, Folsom AR. Reliability of a food frequency questionnaire by ethnicity, gender, age and education. Nutr Res. 1996;16:735–45.
Buckley H. Epidemiology of Gout: Perspectives from the Past. Curr Rheum Rev. 2011;7:106–13.
Gosling AL, Matisoo-Smith E, Merriman TR. Gout in Māori: Modern affliction or ancestral trait? Rheumatology (Oxford). 2014;53:773–4.
Abete I, Perez-Cornago A, Navas-Carretero S, Bondia-Pons I, Zulet MA, Martinez JA. A regular lycopene enriched tomato sauce consumption influences antioxidant status of healthy young subjects: A crossover study. J Func Foods. 2013;5:28–35.
Engelhard YN, Gazer B, Paran E. Natural antioxidants from tomato extract reduce blood pressure in patients with grade-1 hypertension: A double-blind, placebo-controlled pilot study. Am Heart J. 2006;151:100.
Jacob K, Periago MJ, Bohm V, Berruezo GR. Influence of lycopene and vitamin C from tomato juice on biomarkers of oxidative stress and inflammation. Br J Nutr. 2008;99:137–46.
Lee C-YJ, Isaac HB, Huang SH, Long LH, Wang H, Gruber J, et al. Limited antioxidant effect after consumption of a single dose of tomato sauce by young males, despite a rise in plasma lycopene. Free Radic Res. 2009;43:622–8.
Todd AS, Macginley RJ, Schollum JB, Johnson RJ, Williams SM, Sutherland WH, et al. Dietary salt loading impairs arterial vascular reactivity. Am J Clin Nutr. 2010;91:557–64.
Todd AS, Macginley RJ, Schollum JB, Williams SM, Sutherland WH, Mann JI, et al. Dietary sodium loading in normotensive healthy volunteers does not increase arterial vascular reactivity or blood pressure. Nephrology. 2012;17:249–56.
Vinha AF, Barreira SV, Costa AS, Alves RC, Oliveira MB. Pre-meal tomato (Lycopersicon esculentum) intake can have anti-obesity effects in young women? Int J Food Sci Nutr. 2014;65:1019–26.
Wang L, Sweet DH. Potential for food-drug interactions by dietary phenolic acids on human organic anion transporters 1 (SLC22A6), 3 (SLC22A8), and 4 (SLC22A11). Biochem Pharmacol. 2012;84:1088–95.
Anzai N, Endou H. Urate transporters: an evolving field. Semin Nephrol. 2011;31:400–9.
Mattila P, Kumpulainen J. Determination of free and total phenolic acids in plant-derived foods by HPLC with diode-array detection. J Ag Food Chem. 2002;50:3660–7.
Johnson RJ, Nakagawa T, Sanchez-Lozada LG, Lanaspa MA, Tamura Y, Tanabe K, et al. Umami: the taste that drives purine intake. J Rheumatol. 2013;40:1794–6.
Raivio KO, Seegmiller JE. Role of glutamine in purine synthesis and in guanine nucleotide formation in normal fibroblasts and in fibroblasts deficient in hypoxanthine phosphoribosyltransferase activity. Biochim Biophysic Acta. 1973;299:283–92.
McCarty JDJ. Mechanisms of the crystal deposition diseases - gout and pseudogout. Ann Intern Med. 1973;78:767–71.
Erwin CL, Nancollas GH. The crystallization and dissolution of sodium urate. J Crystal Growth. 1981;53:215–23.
Joosten LA, Netea MG, Mylona E, Koenders MI, Malireddi RK, Oosting M, et al. Engagement of fatty acids with toll-like receptor 2 drives interleukin-1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis. Arthritis Rheum. 2010;62:3237–48.
The New Zealand Health Research Council, Lottery Health New Zealand, Arthritis New Zealand and the University of Otago are thanked for funding this study. Ria Akuhata, Nancy Aupouri (Ngati Porou Hauora), Jill Drake (Canterbury District Health Board), Roddi Laurence (University of Auckland) and Gabrielle Sexton are thanked for assistance in recruitment. The authors sincerely thank all participants with gout who donated time and information for this study. The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by the National Heart, Lung and Blood Institute (NHLBI) contracts N01-HC-55015, N01 HC-55016, N01-HC-55018, N01-HC- 55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, R01 HL087641, R01 HL59367, and R01 HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health (NIH) contract HHSN268200625226C. The CHS research reported in this article was supported by contract numbers N01-HC-85079, N01-HC-85080, N01-HC-85081, N01-HC-85082, N01-HC-85083, N01-HC-85084, N01-HC-85085, N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, N01-HC-85239 and HHSN268201200036C; grant numbers U01 HL080295 from the National Heart, Lung, and Blood Institute and R01 AG-023629 from the National Institute on Aging, with additional contribution from the National Institute of Neurological Disorders and Stroke. A full list of principal CHS investigators and institutions can be found at http://www.chs-nhlbi.org/pi. The Framingham Heart Study is supported by NHLBI contract N01-HC-25195. This article was not prepared in collaboration with investigators of the Atherosclerosis Risk in Communities Study, Cardiovascular Health Study or Framingham Heart Study and does not necessarily reflect the opinions or views of these studies, or the NHLBI. The authors thank the staff and participants of the ARIC, CHS and FHS studies for their important contributions.
The authors declare that they have no competing interests.
TJF, RT and TRM helped to design the study, oversee its execution, and prepare the manuscript. ND, PBJ, LKS and JHH helped to provide clinical recruitment and prepare the manuscript. AST and RJW provided data and helped prepare the manuscript. MC helped to analyze data and prepare the manuscript. All authors read and approved the final manuscript.
Characteristics of New Zealand gout study samples. (DOC 65 kb)
ARIC, CHS and FHS food frequency questionnaire answer categories and conversion to serves/week. (DOC 37 kb)
Schematic of exclusions for the Atherosclerosis Risk in Communities (ARIC), Cardiovascular Health Study (CHS) and Framingham Heart Study (FHS). (DOC 132 kb)
Characteristics of publically-available European study samples. (DOC 57 kb)
Association between serum urate levels (μmolL −1) and tomato consumption (serves/week) adjusted for consumption of known serum urate influencing foods in the ARIC, CHS and FHS cohorts. (DOC 71 kb)
Association between serum urate levels (μmolL −1) and consumption of five established urate influencing foods (serves/week) in the ARIC, CHS, FHS and combined cohorts. (DOC 66 kb)